StockData
Clorox Co logo

Clorox Co (CLX) stock analysis

CLXNYSESpecialty Cleaning, Polishing and Sanitation PreparationsFiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 2, 2026Score 14/3046% below fair value
$106.86+0.26 (+0.24%)

Close on Nov 11, 2026Market cap $12.92BP/E 19.2Yield 4.64%

StockData Score

Prices as of Nov 11, 2026How the score works

Value6Growth3Performance2Health0Dividend3

Mixed14 of 30 checks passed

Clorox passes 14 of the 30 checks behind our score; 6 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.

Valuation
6/6
Growth
3/6
Past performance
2/6
Financial health
0/6
Dividend
3/6

What stands out

  • Margin of safety over 20%

    The price is 45.8% below fair value, more than the 20% cushion we look for.

  • Trading below fair value

    The share price of $106.86 is below our fair value estimate of $197.33.

  • EPS growing 10%+ a year

    Diluted EPS grew 58.9% a year over the last three fiscal years.

  • P/E below its 5-year median

    Clorox's P/E of 19.2 is below its own 5-year median of 44.3.

What to watch

  • Earnings shrank over 5 years

    Net income shrank 3.7% a year on average over the last five fiscal years.

  • Revenue growing under 10% a year

    Revenue grew -3.1% a year over the last three fiscal years, short of the 10% we look for.

  • Earnings growth not accelerating

    Net income grew -14.4% over the last twelve months, against a 5-year average of -3.7% a year.

  • Debt not well covered by cash flow

    Operating cash flow over the last twelve months equals 12.8% of total debt; we look for at least 20%.

Valuation6/6
  • P/E below its 5-year median

    Clorox's P/E of 19.2 is below its own 5-year median of 44.3.

  • P/E below the industry

    Clorox's P/E of 19.2 is below the Soap, Detergents, and Cleaning Preparations; Perfumes, Cosmetics, and Other Toilet Preparations median of 29.9.

  • EV/EBITDA below its 5-year median

    Clorox's EV/EBITDA of 13.7 is below its 5-year median of 24.0.

  • P/S below the industry

    Clorox's price-to-sales of 1.80 is below the Soap, Detergents, and Cleaning Preparations; Perfumes, Cosmetics, and Other Toilet Preparations median of 2.66 (book value is negative, so we use sales).

  • Trading below fair value

    The share price of $106.86 is below our fair value estimate of $197.33.

  • Margin of safety over 20%

    The price is 45.8% below fair value, more than the 20% cushion we look for.

Growth3/6
  • Revenue growing under 10% a year

    Revenue grew -3.1% a year over the last three fiscal years, short of the 10% we look for.

  • EPS growing 10%+ a year

    Diluted EPS grew 58.9% a year over the last three fiscal years.

  • Earnings growth not accelerating

    Net income grew -14.4% over the last twelve months, against a 5-year average of -3.7% a year.

  • Growing faster than the industry

    Revenue grew 6.3% over the last twelve months; the Soap, Detergents, and Cleaning Preparations; Perfumes, Cosmetics, and Other Toilet Preparations median is 6.0%.

  • Guidance raised

    Clorox raised its Fiscal Year 2027 effective tax rate outlook on Nov 2, 2026.

  • Gross margin slipping

    Gross margin was 41.9% over the last twelve months, against 44.3% a year earlier.

Past performance2/6
  • Return on equity

    Needs positive equity and five years of results.

  • Return on invested capital

    Needs operating income and invested capital.

  • Return on equity against the industry

    Needs positive equity.

  • Earnings shrank over 5 years

    Net income shrank 3.7% a year on average over the last five fiscal years.

  • Net margin above its 5-year average

    Net margin was 9.4% over the last twelve months, against a 5-year average of 6.5%.

  • Net margin above the industry

    Clorox's net margin of 9.4% is above the Soap, Detergents, and Cleaning Preparations; Perfumes, Cosmetics, and Other Toilet Preparations median of 0.2%.

Financial health0/6
  • Debt level

    Needs debt and equity figures.

  • Debt trend

    Needs a balance sheet from five years ago with positive equity.

  • Debt not well covered by cash flow

    Operating cash flow over the last twelve months equals 12.8% of total debt; we look for at least 20%.

  • Interest coverage

    Interest expense is not reported separately.

  • Short-term assets don't cover short-term debts

    Current assets are 0.65 times current liabilities.

  • Bankruptcy risk in the grey zone

    The Altman Z-score is 1.81; above 3 is the safe zone and below 1.8 the distress zone.

Dividend3/6
  • Pays a dividend

    Clorox paid dividends worth 3.5% of the share price over the last twelve months.

  • Yield below Treasuries

    The 3.5% yield is below the 4.4% on a 1-year Treasury.

  • Yield below the top quarter

    The top quarter of US dividend payers yield 3.8% or more; Clorox yields 3.5%.

  • Dividend not cut

    The dividend per share has not fallen by more than 10% in any of the last 10 fiscal years.

  • Covered by earnings

    Dividends take 88.9% of net income.

  • Not covered by free cash flow

    Dividends take 133% of free cash flow.

Scores of similar companies

Our estimate per share

$197.33

The share price is 46% below this estimate.

20%+ below
Near fair value
20%+ above
$106.86Price$197.33Fair value
MethodMultiple usedOwn 5Y medianIndustry medianValue per shareWeight
P/E37.2×44.3×29.9×$206.6553%
EV/EBITDA21.0×24.0×17.9×$186.6847%
Earnings powerleft out, too far from the others7.4% cost of equity––$61.63–
Fair value$197.33100%

Valuation over time

Using the earnings and balance sheet published at each date, not today's.

  • P/E at month end
  • Own 5-year median 44.3
  • Soap, Detergents, and Cleaning Preparations; Perfumes, Cosmetics, and Other Toilet Preparations median 29.9

An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.

Market risk

From the past year of daily prices.

Liquidity

Low risk

Average value traded per day
$290.42M
Value traded per 1% price move
$155.20M

Downside

Medium risk

Typical loss in a bad month
20.2%
Volatility (annualized)
33%
Sharpe ratio, 1 year
-0.07
Beta to the S&P 500 (5Y)
0.50

Typical bad-month loss, week by week

25%: high

Margins

Share of revenue, fiscal years 2012 to 2026

Gross margin

42.3%−1.3 pts over 5 years

Net margin

8.7%−0.9 pts over 5 years

See a number that looks wrong?